INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,050,036 | -87.5% | 33,208 | -53.4% | 0.00% | -87.5% |
| Q4 2021 | $8,428,000 | -4.0% | 71,282 | +8.9% | 0.01% | -11.1% |
| Q3 2021 | $8,781,000 | -22.9% | 65,456 | -7.0% | 0.01% | -25.0% |
| Q2 2021 | $11,391,000 | +48.9% | 70,351 | -26.2% | 0.01% | +33.3% |
| Q1 2021 | $7,648,000 | +100.8% | 95,297 | +36.1% | 0.01% | +80.0% |
| Q4 2020 | $3,809,000 | +314.5% | 70,014 | +4.0% | 0.01% | +150.0% |
| Q4 2018 | $919,000 | -80.0% | 67,322 | -58.0% | 0.00% | -77.8% |
| Q3 2018 | $4,588,000 | +60.5% | 160,303 | +53.4% | 0.01% | +50.0% |
| Q2 2018 | $2,859,000 | – | 104,505 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |